0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Marine Pharmaceuticals Market Research Report 2026
Published Date: 2026-03-05
|
Report Code: QYRE-Auto-12R2400
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Marine Pharmaceuticals Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Marine Pharmaceuticals Market Research Report 2026

Code: QYRE-Auto-12R2400
Report
2026-03-05
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Marine Pharmaceuticals Market Size

The global Marine Pharmaceuticals market was valued at US$ 37340 million in 2025 and is anticipated to reach US$ 65580 million by 2032, at a CAGR of 8.5% from 2026 to 2032.

Marine Pharmaceuticals Market

Marine Pharmaceuticals Market

The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc. Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential. In our report, we study the drugs and health supplement from marine.
Marine pharmaceuticals refer to natural products with pharmacological activity derived from marine organisms, including small molecule drugs, proteins, glycosaminoglycans, and other forms. These drugs are sourced from marine organisms such as sponges, seaweeds, mollusks, and deep-sea microorganisms, possessing unique structures and biological activities, often used in the treatment of cancer, viral infections, inflammation, and other conditions. With the advancement of marine biodiversity research, marine pharmaceuticals have gradually become a significant focus in new drug development.
The marine pharmaceutical industry is in a phase of rapid development, driven by several factors. Firstly, there is an increasing global demand for new drugs, especially in areas like cancer, viral infections, and inflammation, making marine pharmaceuticals a research hotspot due to their unique biological activities. Secondly, advancements in technologies such as genomics, proteomics, and high-throughput screening have provided strong support for the discovery and development of marine drugs. Additionally, continuous investment from governments and enterprises in marine pharmaceutical research and development is accelerating industry growth.
Despite the promising prospects of the marine pharmaceutical industry, it faces several challenges and risks. Firstly, the research and development cycle for marine drugs is long, costly, and has a low clinical conversion rate, leading to a slow industrialization process. Secondly, the acquisition of marine resources is restricted by environmental protection policies, resulting in unstable resource supply. Moreover, the production processes for marine drugs are complex, and large-scale manufacturing faces both technical and cost pressures.
The downstream demand for marine pharmaceuticals is primarily concentrated in the pharmaceutical, health supplement, and cosmetics industries. With increasing public awareness of health, the demand for natural medicines and functional health products continues to grow. Marine pharmaceuticals, especially in the treatment of chronic diseases such as cancer and autoimmune disorders, are gaining attention due to their unique efficacy. Simultaneously, with the advent of an aging society, the market demand for anti-aging and anti-inflammatory marine drugs is also on the rise.
The upstream raw materials for marine pharmaceuticals mainly include marine biological resources and related biotechnological support. The diversity of marine biological resources provides abundant materials for the development of marine drugs. However, the sustainable acquisition and protection of marine resources have become critical issues. At the same time, advancements in biotechnology, such as gene editing and synthetic biology, offer new pathways for the efficient production of marine pharmaceuticals.
This report delivers a comprehensive overview of the global Marine Pharmaceuticals market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Marine Pharmaceuticals. The Marine Pharmaceuticals market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Marine Pharmaceuticals market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Marine Pharmaceuticals manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Marine Pharmaceuticals Market Report

Report Metric Details
Report Name Marine Pharmaceuticals Market
Accounted market size in 2025 US$ 37340 million
Forecasted market size in 2032 US$ 65580 million
CAGR 8.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Drugs
  • Health Supplement
Segment by Application
  • Hospital & Clinic
  • Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Seattle Genetics, DSM, Eisai Co, Takeda, BASF, Amway, Pfizer, Pelagia (EPAX), Pharma Mar, Croda, GNC, GSK, TerSera Therapeutics, Nordic Naturals, Carlson Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Marine Pharmaceuticals companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Marine Pharmaceuticals Market growing?

Ans: The Marine Pharmaceuticals Market witnessing a CAGR of 8.5% during the forecast period 2026-2032.

What is the Marine Pharmaceuticals Market size in 2032?

Ans: The Marine Pharmaceuticals Market size in 2032 will be US$ 65580 million.

Who are the main players in the Marine Pharmaceuticals Market report?

Ans: The main players in the Marine Pharmaceuticals Market are Seattle Genetics, DSM, Eisai Co, Takeda, BASF, Amway, Pfizer, Pelagia (EPAX), Pharma Mar, Croda, GNC, GSK, TerSera Therapeutics, Nordic Naturals, Carlson Labs

What are the Application segmentation covered in the Marine Pharmaceuticals Market report?

Ans: The Applications covered in the Marine Pharmaceuticals Market report are Hospital & Clinic, Pharmacy, Other

What are the Type segmentation covered in the Marine Pharmaceuticals Market report?

Ans: The Types covered in the Marine Pharmaceuticals Market report are Drugs, Health Supplement

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marine Pharmaceuticals Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drugs
1.2.3 Health Supplement
1.3 Market by Application
1.3.1 Global Marine Pharmaceuticals Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Marine Pharmaceuticals Market Perspective (2021–2032)
2.2 Global Marine Pharmaceuticals Growth Trends by Region
2.2.1 Global Marine Pharmaceuticals Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Marine Pharmaceuticals Historic Market Size by Region (2021–2026)
2.2.3 Marine Pharmaceuticals Forecasted Market Size by Region (2027–2032)
2.3 Marine Pharmaceuticals Market Dynamics
2.3.1 Marine Pharmaceuticals Industry Trends
2.3.2 Marine Pharmaceuticals Market Drivers
2.3.3 Marine Pharmaceuticals Market Challenges
2.3.4 Marine Pharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Marine Pharmaceuticals Players by Revenue
3.1.1 Global Top Marine Pharmaceuticals Players by Revenue (2021–2026)
3.1.2 Global Marine Pharmaceuticals Revenue Market Share by Players (2021–2026)
3.2 Global Top Marine Pharmaceuticals Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Marine Pharmaceuticals Revenue
3.4 Global Marine Pharmaceuticals Market Concentration Ratio
3.4.1 Global Marine Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marine Pharmaceuticals Revenue in 2025
3.5 Global Key Players of Marine Pharmaceuticals Head Offices and Areas Served
3.6 Global Key Players of Marine Pharmaceuticals, Products and Applications
3.7 Global Key Players of Marine Pharmaceuticals, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Marine Pharmaceuticals Breakdown Data by Type
4.1 Global Marine Pharmaceuticals Historic Market Size by Type (2021–2026)
4.2 Global Marine Pharmaceuticals Forecasted Market Size by Type (2027–2032)
5 Marine Pharmaceuticals Breakdown Data by Application
5.1 Global Marine Pharmaceuticals Historic Market Size by Application (2021–2026)
5.2 Global Marine Pharmaceuticals Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Marine Pharmaceuticals Market Size (2021–2032)
6.2 North America Marine Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Marine Pharmaceuticals Market Size by Country (2021–2026)
6.4 North America Marine Pharmaceuticals Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Marine Pharmaceuticals Market Size (2021–2032)
7.2 Europe Marine Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Marine Pharmaceuticals Market Size by Country (2021–2026)
7.4 Europe Marine Pharmaceuticals Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Marine Pharmaceuticals Market Size (2021–2032)
8.2 Asia-Pacific Marine Pharmaceuticals Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Marine Pharmaceuticals Market Size by Region (2021–2026)
8.4 Asia-Pacific Marine Pharmaceuticals Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Marine Pharmaceuticals Market Size (2021–2032)
9.2 Latin America Marine Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Marine Pharmaceuticals Market Size by Country (2021–2026)
9.4 Latin America Marine Pharmaceuticals Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Marine Pharmaceuticals Market Size (2021–2032)
10.2 Middle East & Africa Marine Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Marine Pharmaceuticals Market Size by Country (2021–2026)
10.4 Middle East & Africa Marine Pharmaceuticals Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seattle Genetics
11.1.1 Seattle Genetics Company Details
11.1.2 Seattle Genetics Business Overview
11.1.3 Seattle Genetics Marine Pharmaceuticals Introduction
11.1.4 Seattle Genetics Revenue in Marine Pharmaceuticals Business (2021–2026)
11.1.5 Seattle Genetics Recent Development
11.2 DSM
11.2.1 DSM Company Details
11.2.2 DSM Business Overview
11.2.3 DSM Marine Pharmaceuticals Introduction
11.2.4 DSM Revenue in Marine Pharmaceuticals Business (2021–2026)
11.2.5 DSM Recent Development
11.3 Eisai Co
11.3.1 Eisai Co Company Details
11.3.2 Eisai Co Business Overview
11.3.3 Eisai Co Marine Pharmaceuticals Introduction
11.3.4 Eisai Co Revenue in Marine Pharmaceuticals Business (2021–2026)
11.3.5 Eisai Co Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Marine Pharmaceuticals Introduction
11.4.4 Takeda Revenue in Marine Pharmaceuticals Business (2021–2026)
11.4.5 Takeda Recent Development
11.5 BASF
11.5.1 BASF Company Details
11.5.2 BASF Business Overview
11.5.3 BASF Marine Pharmaceuticals Introduction
11.5.4 BASF Revenue in Marine Pharmaceuticals Business (2021–2026)
11.5.5 BASF Recent Development
11.6 Amway
11.6.1 Amway Company Details
11.6.2 Amway Business Overview
11.6.3 Amway Marine Pharmaceuticals Introduction
11.6.4 Amway Revenue in Marine Pharmaceuticals Business (2021–2026)
11.6.5 Amway Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Marine Pharmaceuticals Introduction
11.7.4 Pfizer Revenue in Marine Pharmaceuticals Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Pelagia (EPAX)
11.8.1 Pelagia (EPAX) Company Details
11.8.2 Pelagia (EPAX) Business Overview
11.8.3 Pelagia (EPAX) Marine Pharmaceuticals Introduction
11.8.4 Pelagia (EPAX) Revenue in Marine Pharmaceuticals Business (2021–2026)
11.8.5 Pelagia (EPAX) Recent Development
11.9 Pharma Mar
11.9.1 Pharma Mar Company Details
11.9.2 Pharma Mar Business Overview
11.9.3 Pharma Mar Marine Pharmaceuticals Introduction
11.9.4 Pharma Mar Revenue in Marine Pharmaceuticals Business (2021–2026)
11.9.5 Pharma Mar Recent Development
11.10 Croda
11.10.1 Croda Company Details
11.10.2 Croda Business Overview
11.10.3 Croda Marine Pharmaceuticals Introduction
11.10.4 Croda Revenue in Marine Pharmaceuticals Business (2021–2026)
11.10.5 Croda Recent Development
11.11 GNC
11.11.1 GNC Company Details
11.11.2 GNC Business Overview
11.11.3 GNC Marine Pharmaceuticals Introduction
11.11.4 GNC Revenue in Marine Pharmaceuticals Business (2021–2026)
11.11.5 GNC Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Marine Pharmaceuticals Introduction
11.12.4 GSK Revenue in Marine Pharmaceuticals Business (2021–2026)
11.12.5 GSK Recent Development
11.13 TerSera Therapeutics
11.13.1 TerSera Therapeutics Company Details
11.13.2 TerSera Therapeutics Business Overview
11.13.3 TerSera Therapeutics Marine Pharmaceuticals Introduction
11.13.4 TerSera Therapeutics Revenue in Marine Pharmaceuticals Business (2021–2026)
11.13.5 TerSera Therapeutics Recent Development
11.14 Nordic Naturals
11.14.1 Nordic Naturals Company Details
11.14.2 Nordic Naturals Business Overview
11.14.3 Nordic Naturals Marine Pharmaceuticals Introduction
11.14.4 Nordic Naturals Revenue in Marine Pharmaceuticals Business (2021–2026)
11.14.5 Nordic Naturals Recent Development
11.15 Carlson Labs
11.15.1 Carlson Labs Company Details
11.15.2 Carlson Labs Business Overview
11.15.3 Carlson Labs Marine Pharmaceuticals Introduction
11.15.4 Carlson Labs Revenue in Marine Pharmaceuticals Business (2021–2026)
11.15.5 Carlson Labs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Marine Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Drugs
 Table 3. Key Players of Health Supplement
 Table 4. Global Marine Pharmaceuticals Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Marine Pharmaceuticals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Marine Pharmaceuticals Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Marine Pharmaceuticals Market Share by Region (2021–2026)
 Table 8. Global Marine Pharmaceuticals Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Marine Pharmaceuticals Market Share by Region (2027–2032)
 Table 10. Marine Pharmaceuticals Market Trends
 Table 11. Marine Pharmaceuticals Market Drivers
 Table 12. Marine Pharmaceuticals Market Challenges
 Table 13. Marine Pharmaceuticals Market Restraints
 Table 14. Global Marine Pharmaceuticals Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Marine Pharmaceuticals Market Share by Players (2021–2026)
 Table 16. Global Top Marine Pharmaceuticals Players by Tier (Tier 1, Tier 2, and Tier 3), based on Marine Pharmaceuticals Revenue, 2025
 Table 17. Ranking of Global Top Marine Pharmaceuticals Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Marine Pharmaceuticals Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Marine Pharmaceuticals, Headquarters and Area Served
 Table 20. Global Key Players of Marine Pharmaceuticals, Products and Applications
 Table 21. Global Key Players of Marine Pharmaceuticals, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Marine Pharmaceuticals Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Marine Pharmaceuticals Revenue Market Share by Type (2021–2026)
 Table 25. Global Marine Pharmaceuticals Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Marine Pharmaceuticals Revenue Market Share by Type (2027–2032)
 Table 27. Global Marine Pharmaceuticals Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Marine Pharmaceuticals Revenue Market Share by Application (2021–2026)
 Table 29. Global Marine Pharmaceuticals Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Marine Pharmaceuticals Revenue Market Share by Application (2027–2032)
 Table 31. North America Marine Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Marine Pharmaceuticals Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Marine Pharmaceuticals Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Marine Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Marine Pharmaceuticals Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Marine Pharmaceuticals Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Marine Pharmaceuticals Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Marine Pharmaceuticals Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Marine Pharmaceuticals Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Marine Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Marine Pharmaceuticals Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Marine Pharmaceuticals Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Marine Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Marine Pharmaceuticals Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Marine Pharmaceuticals Market Size by Country (US$ Million), 2027–2032
 Table 46. Seattle Genetics Company Details
 Table 47. Seattle Genetics Business Overview
 Table 48. Seattle Genetics Marine Pharmaceuticals Product
 Table 49. Seattle Genetics Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 50. Seattle Genetics Recent Development
 Table 51. DSM Company Details
 Table 52. DSM Business Overview
 Table 53. DSM Marine Pharmaceuticals Product
 Table 54. DSM Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 55. DSM Recent Development
 Table 56. Eisai Co Company Details
 Table 57. Eisai Co Business Overview
 Table 58. Eisai Co Marine Pharmaceuticals Product
 Table 59. Eisai Co Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 60. Eisai Co Recent Development
 Table 61. Takeda Company Details
 Table 62. Takeda Business Overview
 Table 63. Takeda Marine Pharmaceuticals Product
 Table 64. Takeda Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 65. Takeda Recent Development
 Table 66. BASF Company Details
 Table 67. BASF Business Overview
 Table 68. BASF Marine Pharmaceuticals Product
 Table 69. BASF Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 70. BASF Recent Development
 Table 71. Amway Company Details
 Table 72. Amway Business Overview
 Table 73. Amway Marine Pharmaceuticals Product
 Table 74. Amway Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 75. Amway Recent Development
 Table 76. Pfizer Company Details
 Table 77. Pfizer Business Overview
 Table 78. Pfizer Marine Pharmaceuticals Product
 Table 79. Pfizer Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 80. Pfizer Recent Development
 Table 81. Pelagia (EPAX) Company Details
 Table 82. Pelagia (EPAX) Business Overview
 Table 83. Pelagia (EPAX) Marine Pharmaceuticals Product
 Table 84. Pelagia (EPAX) Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 85. Pelagia (EPAX) Recent Development
 Table 86. Pharma Mar Company Details
 Table 87. Pharma Mar Business Overview
 Table 88. Pharma Mar Marine Pharmaceuticals Product
 Table 89. Pharma Mar Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 90. Pharma Mar Recent Development
 Table 91. Croda Company Details
 Table 92. Croda Business Overview
 Table 93. Croda Marine Pharmaceuticals Product
 Table 94. Croda Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 95. Croda Recent Development
 Table 96. GNC Company Details
 Table 97. GNC Business Overview
 Table 98. GNC Marine Pharmaceuticals Product
 Table 99. GNC Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 100. GNC Recent Development
 Table 101. GSK Company Details
 Table 102. GSK Business Overview
 Table 103. GSK Marine Pharmaceuticals Product
 Table 104. GSK Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 105. GSK Recent Development
 Table 106. TerSera Therapeutics Company Details
 Table 107. TerSera Therapeutics Business Overview
 Table 108. TerSera Therapeutics Marine Pharmaceuticals Product
 Table 109. TerSera Therapeutics Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 110. TerSera Therapeutics Recent Development
 Table 111. Nordic Naturals Company Details
 Table 112. Nordic Naturals Business Overview
 Table 113. Nordic Naturals Marine Pharmaceuticals Product
 Table 114. Nordic Naturals Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 115. Nordic Naturals Recent Development
 Table 116. Carlson Labs Company Details
 Table 117. Carlson Labs Business Overview
 Table 118. Carlson Labs Marine Pharmaceuticals Product
 Table 119. Carlson Labs Revenue in Marine Pharmaceuticals Business (US$ Million), 2021–2026
 Table 120. Carlson Labs Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Marine Pharmaceuticals Picture
 Figure 2. Global Marine Pharmaceuticals Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Marine Pharmaceuticals Market Share by Type: 2025 vs 2032
 Figure 4. Drugs Features
 Figure 5. Health Supplement Features
 Figure 6. Global Marine Pharmaceuticals Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Marine Pharmaceuticals Market Share by Application: 2025 vs 2032
 Figure 8. Hospital & Clinic Case Studies
 Figure 9. Pharmacy Case Studies
 Figure 10. Other Case Studies
 Figure 11. Marine Pharmaceuticals Report Years Considered
 Figure 12. Global Marine Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Marine Pharmaceuticals Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Marine Pharmaceuticals Market Share by Region: 2025 vs 2032
 Figure 15. Global Marine Pharmaceuticals Market Share by Players in 2025
 Figure 16. Global Marine Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Marine Pharmaceuticals Revenue in 2025
 Figure 18. North America Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Marine Pharmaceuticals Market Share by Country (2021–2032)
 Figure 20. United States Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Marine Pharmaceuticals Market Share by Country (2021–2032)
 Figure 24. Germany Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Marine Pharmaceuticals Market Share by Region (2021–2032)
 Figure 32. China Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Marine Pharmaceuticals Market Share by Country (2021–2032)
 Figure 40. Mexico Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Marine Pharmaceuticals Market Share by Country (2021–2032)
 Figure 44. Israel Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Marine Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Seattle Genetics Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 48. DSM Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 49. Eisai Co Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 50. Takeda Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 51. BASF Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 52. Amway Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 53. Pfizer Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 54. Pelagia (EPAX) Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 55. Pharma Mar Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 56. Croda Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 57. GNC Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 58. GSK Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 59. TerSera Therapeutics Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 60. Nordic Naturals Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 61. Carlson Labs Revenue Growth Rate in Marine Pharmaceuticals Business (2021–2026)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure